GEMINI STUDY: A Phase 3, randomized, double-blind efficacy and safety study comparing SAR442168 to teriflunomide (Aubagio®) in participants with relapsing forms of multiple sclerosis The Neurology team who screened a further 2 patients for the Gemini 2 trial this month which is trialling Tolebrutinib in Relapsing- remitting MS patients. HERCULES STUDY: A Phase 3, randomized,… Read More

GenOMICC Study: Genetics of mortality in Critical Care (Covid & non-Covid patients) Exceeded site target recruitment of 4. As of 22/10/2021 our recruitment is 98. This has been led by Lily Zitter (non-medic PI) UK-ROX STUDY: Evaluating the clinical and cost-effectiveness of a conservative approach to oxygen therapy for invasively ventilated adults in intensive care.… Read More

Caroline Renton has now finished with the Research team (last day was on 5th October) for a job in Information Governance.  We thank her for her contribution to the Department over the years and wish her good luck in her new role. Goodbye and good luck also goes to Lisella Wilkinson who is retiring.  Thank… Read More

Congratulations go to the CRF EXALT Study team, lead by Bijay Vaidya (phase 1 study in Type 1 Diabetes) who have recruited to target and who’s last patient has now closed the study to all recruitment across Europe.  It ended with an emense team effort.  Well done everyone.

The Research Team supported the R&D open day and filled all of the CRF tours where members of the public could see behind the scenes in the CRF. They were given the chance to have a look at the bod pod and undertake some vascular testing with the team.